NK cells engineered with a chimeric antigen receptor delay HIV rebound and reshape HIV reservoir composition
Abstract
Durable HIV remission requires strategies that eliminate or permanently silence the latent reservoir that persists despite antiretroviral therapy (ART). We engineer allogeneic human primary natural killer (NK) cells expressing a truncated CD4-based chimeric antigen receptor (D1D2 CAR) targeting the conserved CD4 binding site on HIV Env. D1D2 CAR NK cells selectively kill HIV-infected primary CD4 T cells in vitro and significantly delay viral rebound following ART interruption in humanized mice infected with barcoded CCR5-tropic HIV. Barcoded HIV tracking shows reductions in the number and diversity of rebounding viral RNA lineages, together with decreased inter-organ sharing of rebound-associated proviral barcodes and integration sites. Integration site and chromatin analyses suggest that rebound-associated proviruses remaining after D1D2 CAR-NK treatment are less frequently located in genic and transcriptionally active chromatin contexts. Thus, CAR-NK cells may target reactivating HIV-infected cells during early ART interruption and shape the composition of the reservoir contributing to rebound.
Related
- Temporal dynamics of immune effector cell‐associated haematotoxicity: Linking early and late cytopenias after chimeric antigen receptor T cells
- Targeting Cardiac Fibrosis with Chimeric Antigen Receptor Neutrophils Derived from Human Pluripotent Stem Cells
- Engineered Chimeric Proteins Functionally Replace ALS-causing Endogenous FUS and TDP-43 to Improve Neuronal Health
- Intrinsic immune receptor triggering mechanism informs rational chimeric receptor design
- A signaling-optimized TIGIT chimeric switch receptor promotes metabolic fitness and antitumor efficacy of TCR/CAR T cells
BibTeX
@article{shi2026cells,
title = {{NK cells engineered with a chimeric antigen receptor delay HIV rebound and reshape HIV reservoir composition}},
author = {Yuan Shi and Izra Abbaali and William Harvey and Matthew Kostelny and Hongying Chen and Alexander Gonzalez and Melanie Dimapasoc and Suwen Li and Amélie Montel-Hagen and Christopher S. Seet and Catherine A. Blish and Jerome A. Zack and Jocelyn T. Kim},
journal = {Nature Communications},
year = {2026},
month = oct,
doi = {10.1038/s41467-026-79036-0},
url = {https://www.nature.com/articles/s41467-026-79036-0},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - NK cells engineered with a chimeric antigen receptor delay HIV rebound and reshape HIV reservoir composition
AU - Yuan Shi
AU - Izra Abbaali
AU - William Harvey
AU - Matthew Kostelny
AU - Hongying Chen
AU - Alexander Gonzalez
AU - Melanie Dimapasoc
AU - Suwen Li
AU - Amélie Montel-Hagen
AU - Christopher S. Seet
AU - Catherine A. Blish
AU - Jerome A. Zack
AU - Jocelyn T. Kim
PY - 2026
DA - 2026/10/27
JO - Nature Communications
DO - 10.1038/s41467-026-79036-0
UR - https://www.nature.com/articles/s41467-026-79036-0
AB - Durable HIV remission requires strategies that eliminate or permanently silence the latent reservoir that persists despite antiretroviral therapy (ART). We engineer allogeneic human primary natural killer (NK) cells expressing a truncated CD4-based chimeric antigen receptor (D1D2 CAR) targeting the conserved CD4 binding site on HIV Env. D1D2 CAR NK cells selectively kill HIV-infected primary CD4 T cells in vitro and significantly delay viral rebound following ART interruption in humanized mice infected with barcoded CCR5-tropic HIV. Barcoded HIV tracking shows reductions in the number and diversity of rebounding viral RNA lineages, together with decreased inter-organ sharing of rebound-associated proviral barcodes and integration sites. Integration site and chromatin analyses suggest that rebound-associated proviruses remaining after D1D2 CAR-NK treatment are less frequently located in genic and transcriptionally active chromatin contexts. Thus, CAR-NK cells may target reactivating HIV-infected cells during early ART interruption and shape the composition of the reservoir contributing to rebound.
SN - 2041-1723
ER -